Cargando…
Primary Myelofibrosis-Related Renal Disorders Treated with a Janus Kinase Inhibitor
Extramedullary hematopoiesis is widely known to occur in patients with primary myelofibrosis (PMF). Autopsy studies on individuals with PMF revealed that extramedullary hematopoiesis occurred in the kidneys in 35% of the cases, but there is little awareness regarding such lesions. A 63-year-old man...
Autores principales: | Asou, Mea, Asakawa, Tomohiko, Araki, Makoto, Ehara, Takashi, Hishima, Tsunekazu, Sakamaki, Hisashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879319/ https://www.ncbi.nlm.nih.gov/pubmed/33614736 http://dx.doi.org/10.1159/000510142 |
Ejemplares similares
-
Fibrillary Glomerulopathy with a High Level of Myeloperoxidase-ANCA: A Case Report
por: Asakawa, Tomohiko, et al.
Publicado: (2020) -
Autoimmune Factor V Deficiency That Took 16 Years to Diagnose due to Pseudodeficiency of Multiple Coagulation Factors
por: Kato, Takaaki, et al.
Publicado: (2021) -
Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report
por: Yasuda, Koya, et al.
Publicado: (2020) -
Managing Patients With Myelofibrosis in the Era of Janus Kinase Inhibitors
por: Knight, Emily A., et al.
Publicado: (2015) -
Azathioprine Hypersensitivity Syndrome during Treatment of Severe Interstitial Lung Disease with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Nakano, Eri, et al.
Publicado: (2020)